What is DNLI's dilution risk score?

DNLI has a latest available DilutionScore record of 31/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for DNLI, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for DNLI?

DilutionWatch tracks 25 SEC filing types for DNLI including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect DNLI shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For DNLI, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for DNLI tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for DNLI. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

DNLI Dilution Risk Score: 31/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

💰 Cash Runway

📊 Float Risk

⚠️ Warrant Exposure

🔄 Convertible Debt

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 0%

No significant dilution signals detected for DNLI.

🔔 Track DNLI — Get forecast alerts →

Market Data

Market Cap$3.03B

Shares Outstanding159.85M

Float144.27M

Cash$710.47M

DebtN/A

Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

Field	Current Value	Basis
DilutionScore	31/100	DilutionWatch score record
Shares Outstanding	159.85M	Verified float table or market cache
Public Float	144.27M	Verified float table or market cache
Market Cap	$3.03B	Market data cache
Cash Runway	19.6 months	DilutionWatch score inputs
Shelf Capacity	None in current score inputs	SEC-derived dilution fields
ATM Capacity	None in current score inputs	SEC-derived dilution fields
Outstanding Warrants	None in current score inputs	SEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 1.

Recent SEC source mix: XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 11.4% shares (2026Q1 vs prior)

272 institutional holders · 172.66M shares

#1 BlackRock, Inc. 13.03M shares

#2 VANGUARD CAPITAL MANAGEMENT LLC 12.30M shares

#3 BAILLIE GIFFORD & CO 12.07M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest15.46M

Days to Cover7.6

% of Float10.7%

FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2020-02-27

Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual DNLI Dilution Snapshot

Denali Therapeutics Inc. (DNLI) has a DilutionScore of 31/100, rated Medium dilution risk. Score date: October 13, 2026.

Recent SEC activity tracked for DNLI: xbrl on 2020-02-27.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

DNLI's DilutionScore is currently 31/100 (Medium risk), with 1 score change tracked over 89 days. The score improved from 27/100 (Medium risk).

Period	Score	Risk Level	Duration
Aug 22 – Oct 13, 2026	31/100	MEDIUM	53 days
Jul 16 – Aug 21, 2026	27/100	MEDIUM	36 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

DNLI shares outstanding have increased 1.6% from 156.16M (Mar 2026) to 158.71M (May 2026). Each increase represents potential dilution to existing shareholders.

Date	Shares Outstanding	Public Float	Change
May 11, 2026	158.71M	144.27M	▲ 0.07%
Apr 28, 2026	158.68M	144.16M	▼ 0.14%
Mar 05, 2026	156.16M	144.36M	▲ 0.15%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track DNLI Dilution Risk in Real-Time

DilutionWatch monitors SEC filings 24/7 and alerts you the moment DNLI files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.

Start Tracking DNLI — Free

Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously